Application landscape of Recombinant Insulin

Wondering what insulin can do to improve patients’ lives? First discovered in 1921 as a life-saver treatment for diabetic patients, the use of insulin has expanded beyond that. With the advancement of technologies for protein expression, insulin has become one of the essential ingredients in the manufacturing process of a broad range of therapeutic molecules. In fact, insulin is currently used as a supplement in cell culture media formulations for producing hundreds of different therapeutics, covering a broad range of medical applications.

From the production of monoclonal antibodies to cell and gene therapies, and vaccines, Novo Nordisk Pharmatech recombinant insulin is contributing to improving the lives of people living with arthritis, cancer, multiple sclerosis, and many more medical conditions.

Want to know more? Take a closer look at the application landscape of our Recombinant Insulin and follow its development into future applications.

Recombinant Insulin
Get the latest insights in our new e-book.